It’s Chemistry, Not Character: Why Weight Regain Is Biology
It's Chemistry, Not Character
Losing weight is one thing. Keeping it off is a different, harder problem.
Most people don't regain weight because they stopped trying. They regain it because their body
changed in ways that were already underway before they noticed.
There is a version of weight loss advice that treats regain as a character problem. You ate too
much. You quit the program. You didn't try hard enough. It's a tidy explanation that fits most of
what we know about willpower, and it's wrong in a way that matters, because it sends people back at
the one problem they're least able to solve with effort.
Here's what the biology actually does.
Your body reads weight loss as a famine signal
Leptin is produced by fat tissue. When you lose fat, leptin falls. Ghrelin, the hormone that makes
you hungry, goes up. Neither shift is subtle.
In a 2011 study from Australia, 50 adults lost an average of 30 pounds on a very low-calorie diet
and were followed for 62 weeks. Leptin, peptide YY, cholecystokinin and amylin all dropped
significantly. Ghrelin rose. So did subjective appetite.
The part that matters isn't the diet. It's the follow-up. A year later, that same group still showed
significant differences from baseline in leptin, ghrelin, peptide YY, and hunger itself. Leptin was
still running about 35% below where it started. The body hadn't failed to return to normal. It had
settled into a new normal, and the new normal was hungry.
This is why the hunger that shows up late in a diet doesn't feel proportionate to the situation. You
are not being tested. You are being regulated. A body that has shed a substantial share of its fat
reads the environment as famine and adjusts accordingly, whether or not the environment in fact
contains enough food.
Satiety is the half nobody talks about
Hunger is the obvious part. Fullness is the part that goes missing.
That same study measured the hormones that signal satiation after a meal. They fell, and they
stayed down. You aren't less full because you're hungrier. You're less full because the signal
itself has weakened.
The distinction matters for how weight comes back. Acute hunger is survivable for months. A quiet,
persistent sense of not-quite-full that you can't quite explain runs for years, and it's much harder
to override. Patients usually call it food noise. Not a craving for any particular thing, just a low
hum of reach.
The arithmetic is not a moral failing. You are eating against a system recalibrated to be hungry,
while the system that told you to stop has been turned down. Reasonable decisions, worse conditions
than you had a year earlier.
The set point doesn't reset
The old framing was that you have a set weight, and you either hold it or drift back. What's actually
happening is subtler.
Your defended weight moves with your circumstances, but the reflexes guarding it stay calibrated to
the old one. Lose 15% of your body weight and those reflexes don't celebrate. They compensate. Energy
expenditure drops beyond what the smaller body explains, and appetite rises. The distance between
those two is where the weight comes back.
This is the uncomfortable part for anyone promising a permanent fix. There isn't one in the
biological sense. What exists instead is treatment that accepts this as a chronic condition rather
than a solved problem.
What the medication data shows now
A few years ago this section would have been thinner, and a lot of what we'd have said about
medications turned out to be wrong. Two corrections matter.
The first is about appetite suppressants. Phentermine and its relatives suppress appetite, and they
do lose weight. They were never studied for maintenance, and as far as the evidence goes they work
while you're taking them. That's a real drug with a real limit. It was never a candidate for keeping
weight off, and any early version of this article implied otherwise.
The second is more useful, because it's the opposite of what was expected.
When semaglutide first produced double-digit weight loss, the assumption was that the drug worked
better because it suppressed appetite harder, and that when you stopped, you'd stop losing. The
long-term data says something different. The effect of these drugs on appetite and satiety appears to
persist well beyond the period of weight loss itself. People who stop them aren't simply reverting to
their old self — they're reverting to a self that has been meaningfully recalibrated, and then
finding themselves without the support that made it manageable.
The clearest evidence is the STEP 1 extension, which followed semaglutide patients after they went
off treatment. One year out, they had regained roughly two-thirds of what they'd lost, and their
cardiometabolic markers moved back toward baseline along with the weight.
Read that carefully, because it cuts both ways. It's the strongest proof that the defended weight
does not reset on its own. It's also the reason so many people are still confused about whether these
drugs "keep weight off" or merely hold it. They do both, while you take them. The maintenance
question was never settled by the weight loss data alone.
STEP 4 ran the comparison in the other direction. Patients who stayed on semaglutide kept losing
weight. Patients switched to placebo regained it.
So the difference between older and newer drugs isn't that one loses weight and the other keeps it
off. It's that the newer ones have been studied for maintenance long enough to know how they're
supposed to be used, and the older ones haven't.
The part that should change your plan
If all of this is true, then losing the weight isn't the achievement. Declaring victory is the error.
The people who hold their weight well aren't the ones with the most willpower or the lowest number
on the scale. They're the ones who expected the hunger to return, because they know where it comes
from, and who built a plan for the year it shows up. They treat everything after the first six months
as the actual treatment.
That's a different conversation than most weight loss practices end with. "Great results, keep
doing what you're doing" is aimed at someone who has no idea that hunger is about to climb, that
fullness is about to drop, and that both of those are going to feel like willpower failing.
None of this is an argument for pessimism. It's an argument for planning. Weight management isn't a
phase of your life. It's a set of conditions you can anticipate, and most of the damage comes from
not anticipating them.
The patients I see who hold it best are rarely the ones who tried hardest. They're the ones who
understood the biology early enough to build around it, and who didn't experience the return of
hunger as evidence that something was wrong with them. It was evidence that they were human.
Questions patients ask
**Is regain really predictable?**
More than most people expect. The hormone shifts in the 2011 study were still measurably present a
year after weight loss, and they aren't unusual. They follow the physics of losing fat.
**Does this mean I have to stay on medication forever?**
It means the decision is a clinical one that has to be made deliberately rather than by stopping
quietly and hoping. The STEP 1 extension is the evidence for why that matters, and it's also why
dose changes belong in a conversation with your physician instead of a self-directed adjustment.
**What actually helps with maintenance?**
Protein intake, resistance training, sleep, and honest expectations all matter. None of them
overcome the hormonal shift on their own, which is why the treatments that do work tend to be
pharmacologic.
**Was I just not disciplined enough?**
No. The appetite and satiety changes described here were measured, not assumed, and they occur in
people who are being completely disciplined.
*Dr. Ethan Lazarus, MD, DABOM, DABFM, MFOMA — Clinical Nutrition Center, Greenwood Village, Colorado*
Sources
Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, Proietto J. Long-term
persistence of hormonal adaptations to weight loss. *N Engl J Med.* 2011;365(17):1597-1604.
doi:10.1056/NEJMoa1105816
Wilding JPH, Batterham RL, Davies M, et al.; STEP 1 Study Group. Weight regain and cardiometabolic
effects after withdrawal of semaglutide: the STEP 1 trial extension. *Diabetes Obes Metab.*
2022;24(8):1553-1564. doi:10.1111/dom.14725
Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs
placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized
clinical trial. *JAMA.* 2021;325(14):1414-1425. doi:10.1001/jama.2021.3224
